142 related articles for article (PubMed ID: 2498342)
1. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
Wilson C
J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
[TBL] [Abstract][Full Text] [Related]
2. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate.
Kuromaru O; Sakai K
Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572
[TBL] [Abstract][Full Text] [Related]
3. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
4. Effect of cromakalim on contractions in rabbit isolated renal artery in the presence and absence of extracellular Ca2+.
Wilson C; Cooper SM
Br J Pharmacol; 1989 Dec; 98(4):1303-11. PubMed ID: 2575415
[TBL] [Abstract][Full Text] [Related]
5. Evidence that imidazol(id)ine- and sulphonylurea-based antagonists of cromakalim act at different sites in the rat thoracic aorta.
Challinor JL; McPherson GA
Clin Exp Pharmacol Physiol; 1993; 20(7-8):467-75. PubMed ID: 8403526
[TBL] [Abstract][Full Text] [Related]
6. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
Masuzawa K; Matsuda T; Asano M
Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
[TBL] [Abstract][Full Text] [Related]
7. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660.
Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ
Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155
[TBL] [Abstract][Full Text] [Related]
8. Effects of antidiabetic sulphonylureas, cromakalim and their interaction in guinea-pig isolated tracheal smooth muscle.
Nielsen-Kudsk JE; Thirstrup S
Pulm Pharmacol; 1993 Sep; 6(3):185-92. PubMed ID: 8219573
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
[TBL] [Abstract][Full Text] [Related]
10. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
Satoh E; Yanagisawa T; Taira N
Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
13. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
Eltze M
Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic sulfonylureas antagonize the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta.
Lebrun P; Fang ZY; Antoine MH; Herchuelz A; Hermann M; Berkenboom G; Fontaine J
Pharmacology; 1990; 41(1):36-48. PubMed ID: 2122482
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the effects of potassium channel modulating agents on mouse intestinal smooth muscle.
Yeung CK; McCurrie JR; Wood D
J Pharm Pharmacol; 2002 Mar; 54(3):425-33. PubMed ID: 11902810
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
18. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
19. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
Meisheri KD; Khan SA; Martin JL
J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
